Although conducted using NSCLC cells without ALK rearrangement, this study provides a clue to the fact that intracellular changes by PEM are related to the EGFR signaling system and the utility of a treatment strategy using EGFR inhibitors after PEM. The gene discussed is ALK; the disease is non-small cell lung carcinoma.